KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Cash from Financing Activities (2016 - 2025)

Colgate Palmolive (CL) has 17 years of Cash from Financing Activities data on record, last reported at -$1.4 billion in Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 6.41% year-over-year to -$1.4 billion; the TTM value through Dec 2025 reached -$3.3 billion, up 3.92%, while the annual FY2025 figure was -$3.3 billion, 3.92% up from the prior year.
  • Cash from Financing Activities reached -$1.4 billion in Q4 2025 per CL's latest filing, down from -$1.0 billion in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $99.0 million in Q3 2022 and bottomed at -$1.4 billion in Q4 2025.
  • Average Cash from Financing Activities over 5 years is -$658.2 million, with a median of -$623.0 million recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 112.63% in 2022, then tumbled 954.55% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at -$1.1 billion in 2021, then skyrocketed by 39.78% to -$666.0 million in 2022, then tumbled by 48.95% to -$992.0 million in 2023, then fell by 28.93% to -$1.3 billion in 2024, then dropped by 6.41% to -$1.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$1.4 billion in Q4 2025, -$1.0 billion in Q3 2025, and -$409.0 million in Q2 2025.